These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. T cell regulation of autoimmune interstitial nephritis. Kelly CJ J Am Soc Nephrol; 1990 Aug; 1(2):140-9. PubMed ID: 1983335 [TBL] [Abstract][Full Text] [Related]
3. Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease. Barabas AZ; Cole CD; Lafreniere R; Weir DM Autoimmunity; 2012 Nov; 45(7):495-509. PubMed ID: 22816962 [TBL] [Abstract][Full Text] [Related]
4. The selection of effector T cell phenotype by contrasuppression modulates susceptibility to autoimmune injury. Kelly CJ; Mok H; Neilson EG J Immunol; 1988 Nov; 141(9):3022-8. PubMed ID: 2902142 [TBL] [Abstract][Full Text] [Related]
5. [Pathogenic mechanisms of autoimmune diseases]. Bonnotte B Rev Med Interne; 2004 Sep; 25(9):648-58. PubMed ID: 15363620 [TBL] [Abstract][Full Text] [Related]
6. The NLRP3 inflammasome in kidney disease and autoimmunity. Hutton HL; Ooi JD; Holdsworth SR; Kitching AR Nephrology (Carlton); 2016 Sep; 21(9):736-44. PubMed ID: 27011059 [TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells in immune-mediated renal disease. Ghali JR; Wang YM; Holdsworth SR; Kitching AR Nephrology (Carlton); 2016 Feb; 21(2):86-96. PubMed ID: 26206106 [TBL] [Abstract][Full Text] [Related]
9. Molecules Great and Small: The Complement System. Mathern DR; Heeger PS Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220 [TBL] [Abstract][Full Text] [Related]
10. Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritis. Meyers CM; Kelly CJ J Clin Invest; 1991 Aug; 88(2):408-16. PubMed ID: 1907613 [TBL] [Abstract][Full Text] [Related]
11. Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis. Miettinen A; Törnroth T; Ekblom P; Virtanen I; Linder E Lab Invest; 1984 Apr; 50(4):435-46. PubMed ID: 6708453 [TBL] [Abstract][Full Text] [Related]
12. No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs). Vlachoyiannopoulos PG; Petrovas C; Tzioufas AG; Alexopoulos C; Tsikaris V; Guialis A; Nakopoulou L; Sakarellos-Daitsiotis M; Sakarellos C; Davaris P; Moutsopoulos HM J Autoimmun; 2000 Feb; 14(1):53-61. PubMed ID: 10648116 [TBL] [Abstract][Full Text] [Related]
16. The immune system and kidney disease: basic concepts and clinical implications. Kurts C; Panzer U; Anders HJ; Rees AJ Nat Rev Immunol; 2013 Oct; 13(10):738-53. PubMed ID: 24037418 [TBL] [Abstract][Full Text] [Related]
17. Immune-mediated kidney disease in 2017: Progress in mechanisms and therapy for immunological kidney disease. Holdsworth SR; Kitching AR Nat Rev Nephrol; 2018 Feb; 14(2):76-78. PubMed ID: 29292371 [No Abstract] [Full Text] [Related]